These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25937014)

  • 61. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents.
    Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Diastereoselective synthesis of substituted hexahydrobenzo[de]isochromanes and evaluation of their antileishmanial activity.
    Saikia AK; Sultana S; Devi NR; Deka MJ; Tiwari K; Dubey VK
    Org Biomol Chem; 2016 Jan; 14(3):970-9. PubMed ID: 26625982
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei.
    del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL
    Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase.
    Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK
    Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
    Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
    Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
    Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
    Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
    Guglielmo S; Bertinaria M; Rolando B; Crosetti M; Fruttero R; Yardley V; Croft SL; Gasco A
    Eur J Med Chem; 2009 Dec; 44(12):5071-9. PubMed ID: 19811859
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation.
    Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK
    J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis.
    Ogungbe IV; Ng JD; Setzer WN
    Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.
    Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN
    Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani.
    Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM
    Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
    Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
    Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antiprotozoal properties of 16,17-dihydrobrachycalyxolide from Vernonia brachycalyx.
    Oketch-Rabah HA; Brøgger Christensen S; Frydenvang K; Dossaji SF; Theander TG; Cornett C; Watkins WM; Kharazmi A; Lemmich E
    Planta Med; 1998 Aug; 64(6):559-62. PubMed ID: 9741304
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Invention of anti-Leishmania drugs on the basis of the nucleoside structures.
    Wataya Y; Tanifuji H; Kubochi F; Yoshioka-Hiramoto A; Morishige K; Ishii A; Morizawa Y; Nakayama T; Yasuda A; Matsuda A
    Nucleic Acids Symp Ser; 1990; (22):23-4. PubMed ID: 2101903
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
    Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.
    Suryawanshi SN; Chandra N; Kumar P; Porwal J; Gupta S
    Eur J Med Chem; 2008 Nov; 43(11):2473-8. PubMed ID: 18243420
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
    Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
    J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Structure-based discovery of the first non-covalent inhibitors of Leishmania major tryparedoxin peroxidase by high throughput docking.
    Brindisi M; Brogi S; Relitti N; Vallone A; Butini S; Gemma S; Novellino E; Colotti G; Angiulli G; Di Chiaro F; Fiorillo A; Ilari A; Campiani G
    Sci Rep; 2015 May; 5():9705. PubMed ID: 25951439
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An antileishmanial chalcone from Chinese licorice roots.
    Christensen SB; Ming C; Andersen L; Hjørne U; Olsen CE; Cornett C; Theander TG; Kharazmi A
    Planta Med; 1994 Apr; 60(2):121-3. PubMed ID: 8202561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.